Express Pharma
APRIL 8, 2025
A successful campaign drives engagement and shapes social norms through consistent digital communication – Bhavna Singh, Vice President Corporate Communications at Bharat Serums and Vaccines (BSV) “Communication is as effective as the content and the channels used. Digital Multi stakeholder communication rests heavily on engagement with the audience.
European Pharmaceutical Review
APRIL 22, 2025
New Phase III data has demonstrated the potential benefit of the monoclonal antibody obinutuzumab to treat lupus nephritis. This therapy is already approved for B cell malignancies. The REGENCY Phase III clinical trial evaluated 271 adults with active lupus nephritis, a severe complication of lupus that inhibits kidney function. Participants were randomised to receive either obinutuzumab plus mycophenolate mofetil and glucocorticoids as standard therapy, or a placebo plus standard therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
APRIL 27, 2025
Introduction In todays hyper-competitive healthcare space, building a Lead Generation Network in pharma is no longer optionalits essential. Much like a clinical trial needs carefully selected participants, pharma marketers must construct targeted networks to generate high-quality leads. But how does one translate an abstract marketing concept into a practical strategy that complies with strict regulatory frameworks while producing measurable outcomes?
STAT
APRIL 4, 2025
After Hurricane Ian, as Floridians returned home to sodden furniture and moldy piles of debris, many with asthma could feel their chests tightening. To figure out what was safe, some sent their concerns directly to the U.S. Centers for Disease Control and Prevention. But on Tuesday — days before floods ravaged Nashville, potentially prompting similar queries — the people who would normally answer such asthma questions stopped working.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
FDA Law Blog: Biosimilars
APRIL 8, 2025
By Kurt R. Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As the dust begins to settle and we all assess what this means for the future of FDA and the public health, generally, this blogger wanted to call out one particular division in the Office of Generic Drugs (OGD), funded by user fees under the Generic Drug User Fee Amendments (GDUFA), that was eradicated and what t
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Putting Patients First Blog
APRIL 17, 2025
NHC Letter to Congress: Protect Medicaid Access for Americans with Chronic Conditions and Disabilities (PDF) April 17, 2025 The Honorable John Thune The Honorable Chuck Schumer Majority Leader Minority Leader United States Senate United States Senate Washington, DC 20510 Washington, DC 20510 The Honorable Mike Johnson The Honorable Hakeem Jeffries Speaker Minority Leader U.S.
European Pharmaceutical Review
APRIL 21, 2025
For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.
Express Pharma
APRIL 23, 2025
Indias pharma and healthcare sector recorded 71 deals amounting to USD 2.6 billion in Q1 2025, according to the Grant Thornton Bharat Pharma & Healthcare Dealtracker. While this marks a 5 per cent decline in deal volume and a 69 per cent drop in deal value compared to Q4 2024, the report notes continued investor interest. Mergers and acquisitions (M&A) accounted for 57 per cent of the total deal value, while private equity (PE) made up 59 per cent of the overall deal volume.
STAT
APRIL 22, 2025
Imagine a clinical trial with sedentary, overweight adults. One group is assigned to remain sedentary, the other to undergo intensive physical training with daily runs, calisthenics, and sports. After a week or two, the training group would probably feel sore and tired, and their endurance might be reduced. But we wouldn’t conclude that physical activity is bad for health.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmafile
APRIL 1, 2025
Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the companys phase 3 trial of the therapy. The ROSELLA trial enrolled 381 patients with platinum-resistant ovarian cancer across sites internationally. Patients were randomised 1:1 to receive either relacorilant plus nab-paclitaxel or nab-paclitaxel alone.
PharmaVoice
APRIL 2, 2025
Amid widespread staff reductions at health agencies, a number of key officials have bid farewell to pharma’s top regulator.
The Pharmacist
APRIL 29, 2025
Olivier Picard has taken over as the new chair of the National Pharmacy Association (NPA), alongside the organisation's first-ever female vice chair Sukhi Basra. Baldev Bange has become the NPA treasurer, while Mike Hewitson, Dave Thomas and Joanne Wolfe have joined the board until March 2027. And for the next two years, Mike Hewitson and […] The post New NPA chair takes over alongside first female vice chair appeared first on The Pharmacist.
Drug Channels
APRIL 9, 2025
It's time for Drug Channels annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. drug channels. As you can see below, we have revised, renovated, and refurbished our infamous illustration of the major vertical business relationships among the largest companies. Proponents of these vertical integration arrangements argue that they create opportunities to mine healthcare costs.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
APRIL 14, 2025
At the recently held 2025 American Academy of Neurology (AAN) meeting, Remegen presented positive Phase III results for telitacicept in patients with AChR+ or MuSK+ generalised myasthenia gravis (gMG). The B cell-targeting therapy demonstrated a favorable efficacy and safety profile over 24 weeks, showing clinically meaningful improvement. These findings position telitacicept as a potential challenger to the existing disease-modifying therapies (DMTs), says GlobalData.
STAT
APRIL 13, 2025
In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest pharmacy benefit managers in the United States, violated state laws in its dealings with pharmacies, according to newly released documents. Specifically, the company failed to properly reimburse pharmacies, favored its own specialty pharmacy operations by paying higher dispensing fees than to other pharmacies, and did not properly handle appeals filed by pharmacies, accor
Drug Patent Watch
APRIL 9, 2025
"Unlocking New Hope for Neurological Disorders As we continue to push the boundaries of medical innovation, I'm excited to share with you a game-changing development in the fight against neurological disorders. At the forefront of this revolution is AI-based drug repurposing. By leveraging cutting-edge technology, researchers are re-examining existing medications to identify new uses for treating conditions such as Alzheimer's, Parkinson's, and multiple sclerosis.
PharmaVoice
APRIL 18, 2025
Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
National Association of Boards of Pharmacy
APRIL 16, 2025
At NABP, we offer pharmacist examinations like the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE) to assess a pharmacists competency to practice while protecting the public health. In our last blog post, we discussed the development and the recent improvements that have been made to the MPJE and its purpose: to evaluate candidates understanding and application of federal and state-specific laws and regulations.
The Pharmacist
APRIL 23, 2025
The Royal Pharmaceutical Society (RPS) is recruiting for a new director for England after previous postholder Dr James Davies left the role at the end of last year. Applicants for the 80,000-85,000 director for England role must be a pharmacist, an RPS member, and have experience or knowledge of more than one sector in pharmacy […] The post New leadership role created at RPS as director for England sought appeared first on The Pharmacist.
Express Pharma
APRIL 12, 2025
Panellists in this video: Mr Ajay Bapat, Pharma Consultant (MODERATOR) Mr Manoj Kumar, Cluster Lead Packaging, Sun Pharma Mr Prafull V Deshpande, Team leader Packaging Development, Lupin Mr Kumar Suman, AGM & Head Packaging Development (Injectables and Medical Devices), Macleods Pharmaceuticals Mr Iranna SB, VP MSAT, Maiva Pharma Key Highlights: [1] Any innovation is truly successful only when it generates business value or is cost-efficient [2] The industry should actively promote
STAT
APRIL 9, 2025
A national public health organization is calling for Health Secretary Robert F. Kennedy Jr. to resign the federal post he assumed just weeks ago, citing “implicit and explicit bias and complete disregard for science.” Georges Benjamin, executive director of the American Public Health Association, said in a statement on Wednesday that concerns raised during Kennedy’s confirmation hearing last month have been realized, followed by massive reductions in staff at key health agen
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
European Pharmaceutical Review
APRIL 11, 2025
The National Institute For Health and Care Excellence ( NICE )s has recommended a new combination treatment for advanced breast cancer patients. AstraZenecas Truqap (capivasertib) in combination with fulvestrant is indicated as a treatment option for around 1,100 UK adults with hormone receptor (HR)-positive HER2-negative breast cancer with certain genetic mutations.
PharmaVoice
APRIL 29, 2025
U.S. health agencies are taking the fight to vaccine and mRNA research, which could have lasting repercussions on medical and scientific advancements.
Drug Patent Watch
APRIL 1, 2025
The Biosimilar Revolution: How Europe's Generic Drug Industry is Evolving As we navigate the ever-changing landscape of the pharmaceutical industry, one trend is clear: biosimilars are here to stay. In Europe, the generic drug industry is undergoing a significant transformation, driven by the increasing adoption of biosimilars. But what does this mean for the industry as a whole, and how will it impact the way we approach healthcare?
Pharmafile
APRIL 14, 2025
Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for a rare form of dry age-related macular degeneration (AMD), geographic atrophy (GA). GA is an advanced form of AMD, which affects a small number of AMD patients. The phase 1 trial found advancement in visual […] The post Successful trial results announced for potential rare eye disease treatment appeared first on Pharmafile.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
APRIL 29, 2025
he Authentication Solution Providers Association (ASPA) conducted its MEA Open House on April 24 2025 at Anantara Downtown Dubai. The event brought together 46 delegates representing 17 companies from the authentication, packaging, and brand protection industries. The initiative was part of ASPAs strategy to expand its presence and strengthen collaborative efforts to combat counterfeiting in the Middle East and Africa (MEA) region.
STAT
APRIL 14, 2025
An estimated 4 million Americans are infected with hepatitis C, a disease that can go undetected for years. Another 2.4 million people in this country are chronically infected with hepatitis B, which is the leading cause of liver cancer globally. Hepatitis B is preventable, and hepatitis C is curable. But the U.S. capacity to battle these viral scourges has been leveled a devastating blow with the April 1 closure of the country’s premier testing laboratory for viral hepatitis, experts war
Pharma Marketing Network
APRIL 7, 2025
How do pharma brands cut through the noise and bring the right audiences to their digital doorstep? As digital channels continue to expand, identifying and optimizing the best traffic drivers has become more critical than ever for pharma marketing teams. In this article, well unpack the most effective sources of website traffic in 2025from organic search to paid campaignsand explore how marketing leaders can turn clicks into meaningful engagement.
Expert insights. Personalized for you.
101 
Let's personalize your content